Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/10/2020 6:19:57 PM - Followers: 79 - Board type: Free - Posts Today: 0

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#2249   Earnings report was great. I guess no one cares. cardmaster114 03/10/20 06:19:56 PM
#2248   Now, it has to get back over a Three2001 03/10/20 03:27:14 PM
#2247   Stock getting killed. What now ? Got lucky, cardmaster114 03/10/20 12:36:30 PM
#2246   No pump. Moving on news Trons 02/20/20 09:03:10 AM
#2245   Where is the pump? a couple of ErnieBilco 02/03/20 06:04:29 PM
#2244   Good old fashioned pump and dump!!! cardmaster114 02/03/20 04:04:47 PM
#2243   Is something going on here? Trons 01/30/20 08:51:12 PM
#2242   Got my tickers mixed up wasn't NSPR but ErnieBilco 01/21/20 09:49:27 AM
#2241   where did you see that Ernie? novicetrader 01/21/20 08:21:43 AM
#2240   They have cancelled their desire to do a ErnieBilco 01/18/20 08:58:44 AM
#2239   Any reason for the spike on more than novicetrader 01/18/20 01:18:54 AM
#2238   Warrants had a huge day ErnieBilco 01/17/20 08:36:59 PM
#2237   * * $NSPR Video Chart 01-17-2020 * * ClayTrader 01/17/20 06:19:15 PM
#2236   Heavy buying Trons 12/31/19 02:37:32 PM
#2235   Bullish Trons 12/31/19 02:36:42 PM
#2234   This is a Repeated Giant diluting and Huge Value_Investor 12/20/19 04:55:13 PM
#2233   Good chunk of money with that buy. Garyst 12/20/19 11:37:21 AM
#2232   An institutional buyer bought 24,408 shares at 10.33 cardmaster114 12/20/19 11:14:46 AM
#2231   Yep. Day traders kill a lot of them lately Garyst 11/26/19 08:47:08 PM
#2230   this stock use to be over $5 less cash_cow1 11/26/19 07:34:33 PM
#2229   Huge volume from the jump off, until InspireMD, cash_cow1 11/26/19 07:27:08 PM
#2228   Big volume day today on the filing. Garyst 11/26/19 06:17:29 PM
#2227   * * $NSPR Video Chart 11-26-2019 * * ClayTrader 11/26/19 06:08:07 PM
#2226   Please get back to $5. cash_cow1 11/26/19 03:53:43 PM
#2225   These Tel a viv put out a pr cash_cow1 11/26/19 01:52:48 PM
#2224   They must be dumping a shitload of shares. Lenard 11/26/19 10:32:53 AM
#2223   News: $NSPR InspireMD Reports Updated Positive CGuard(TM) EPS whytestocks 11/26/19 10:15:35 AM
#2222   * * $NSPR Video Chart 09-20-2019 * * ClayTrader 09/20/19 04:28:09 PM
#2221   Hoping to buy a few here, and hoping RJ Trotts 09/20/19 01:04:08 PM
#2220   I think they purposely released that news after Three2001 09/20/19 10:37:25 AM
#2219   NSPR falling and the warrant NSPR.WS is going Daytrader2013 09/20/19 09:07:16 AM
#2218   Dilution?!? Glider549 09/20/19 07:08:14 AM
#2217   I bought after hours today. What an idiot. KryptoKelso 09/19/19 10:10:26 PM
#2216   Wow, $1.80, are you fraking kidding me? Thought Three2001 09/19/19 09:38:19 PM
#2215   I would be very careful dilution coming dinogreeves 09/17/19 06:39:28 PM
#2214   Hit $4.42 AH, now at $4.21 Papalaka 09/17/19 06:16:15 PM
#2213   Looking good here Papalaka 09/17/19 02:35:52 PM
#2212   News: $NSPR InspireMD Provides Business Update whytestocks 09/09/19 11:20:25 AM
#2211   News: $NSPR InspireMD to Present at the HC whytestocks 09/09/19 11:10:22 AM
#2210   Watch for the sudden appearance of moderators. ErnieBilco 09/06/19 09:31:47 PM
#2209   Impressive silence here, when, at last, something is pberger 09/06/19 02:38:03 PM
#2208   Not a single share traded in PM one pberger 08/27/19 08:29:14 AM
#2207   * * $NSPR Video Chart 08-21-2019 * * ClayTrader 08/21/19 06:39:01 PM
#2206   What's beyond all this trading activity? Nothing???? Really???????? pberger 08/21/19 03:08:50 PM
#2205   Is a group behind this? pberger 08/21/19 01:48:51 PM
#2204   classic pump & DUMP Disquisition 08/21/19 12:42:11 PM
#2203   News: $NSPR Have an attention on- InspireMD, Inc. (NYSE:NSPR) whytestocks 08/21/19 11:50:29 AM
#2202   News: $NSPR Lookout for Price Target? InspireMD, Inc. (NYSE:NSPR) whytestocks 08/19/19 11:10:29 AM
#2201   The stock is undervalued. But a dilution comes Bernardo75 08/03/19 12:59:30 PM
#2200   NSPR+ Adding Next Week Becks83 06/29/19 01:05:55 AM
PostSubject